We suspect that Toll-like receptor 2 and Toll-like receptor 4 signaling pathways may promote Parkinson’s disease pathogenesis by increasing gut permeability and gut inflammation, thereby driving α-synuclein aggregation in the gut or brain. The gene discussed is TLR4; the disease is Parkinson disease.